Mn Services Vermogensbeheer B.V. Sells 18,400 Shares of Colgate-Palmolive (NYSE:CL)

Mn Services Vermogensbeheer B.V. reduced its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 6.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 289,019 shares of the company's stock after selling 18,400 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in Colgate-Palmolive were worth $27,081,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Aviva PLC raised its position in shares of Colgate-Palmolive by 13.4% during the fourth quarter. Aviva PLC now owns 973,421 shares of the company's stock valued at $88,494,000 after buying an additional 114,855 shares during the last quarter. Atlas Legacy Advisors LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at approximately $311,000. SBI Securities Co. Ltd. acquired a new position in Colgate-Palmolive in the 4th quarter valued at approximately $304,000. Jupiter Asset Management Ltd. lifted its position in shares of Colgate-Palmolive by 2.3% in the 4th quarter. Jupiter Asset Management Ltd. now owns 685,718 shares of the company's stock worth $62,339,000 after acquiring an additional 15,142 shares during the period. Finally, Summit Investment Advisors Inc. grew its holdings in shares of Colgate-Palmolive by 10.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 32,710 shares of the company's stock worth $2,974,000 after purchasing an additional 3,187 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CL has been the subject of a number of analyst reports. Citigroup raised their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. UBS Group raised their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. Wall Street Zen cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Finally, JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $102.12.

Colgate-Palmolive Stock Down 3.2%

Shares of NYSE CL traded down $2.94 during trading on Friday, hitting $90.20. The stock had a trading volume of 5,331,970 shares, compared to its average volume of 4,757,255. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a fifty day moving average of $91.75 and a two-hundred day moving average of $91.03. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a market capitalization of $73.10 billion, a PE ratio of 25.63, a PEG ratio of 4.20 and a beta of 0.38.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The firm's quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.86 earnings per share. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has authorized a share repurchase plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's payout ratio is presently 58.76%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.